Kevin T. Schomacker is the Vice President of Medical Research at Candela Corporation, leading a global team in developing lasers and other energy-based devices for aesthetic applications. Dr. Schomacker holds a Ph.D. in chemical physics, has conducted extensive research in non-invasive and minimally invasive optical techniques, and brings 20 years of experience developing medical devices to the Removery team. Dr. Schomacker has conducted postdoctoral research at the Wellman Center of Photomedicine, expanding into an associate physicist position, as well as an assistant professor in Dermatology at Harvard Medical School. Dr. Schomacker serves a pivotal role in investigating laser-tissue interactions, such as tattoo clearance.
At Removery, we are committed to providing every individual with clear, credible, evidence-based health and wellness information. To be your most trusted source of tattoo removal information, our content is medically reviewed to verify the clinical accuracy of our content, images, products, and services. All noted content has been reviewed by members of our Clinical Advisory Board.
Clinical Paper- The first commercial 730 nm picosecond-domain laser is safe and effective for treating multicolor tattoos March 24, 2020 This study examined several males and females who had tattoos removed thanks to treatment from a 730 nm titanium-sapphire laser-pumped laser. A blind assessment showed clearance in varying degrees for six different colors of pigments without scarring or pigmentary alteration.
We’re on a mission to give you the most straightforward, easy and efficient laser tattoo removal experience. Your estimate will be entirely bespoke to your tattoo; the size, the colors, the ink. It won’t take long and afterwards you’ll have a plan to finally get rid of your unwanted tattoo and get back to being you.
866-465-0090